Name | mahma nonoate |
---|---|
Synonyms |
MFCD01310509
METHYLAMINE HEXAMETHYLENE METHYLAMINE NONOATE noc-9crystalline 2-Hydroxy-1-methyl-1-[6-(methylamino)hexyl]-3-oxotriazane 6-(2-Hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine NOC-9 1-Hexanamine, 6-(2-hydroxy-1-methyl-3-oxotriazanyl)-N-methyl- NOC-9 MAHMA/NO |
Description | MAHMA NONOate is a NO donor. MAHMA NONOate effectively inhibits platelet aggregation induced by either collagen or ADP[1]. |
---|---|
Related Catalog | |
In Vitro | MAHMA NONOate (0.1 nM-100 μM) dose-dependently inhibits platelet aggregation induced by either collagen or ADP[1]. MAHMA NONOate shows inhibitory effects to pulmonary artery and platelet aggregation with log IC50 values of 7.18 and 6.16, respectively[1]. |
In Vivo | MAHMA NONOate (0.3-10 nmol/kg/min; i.v. once) shows both platelet inhibitory and vasodepressor effects in vivo[2]. Animal Model: Male Wistar rats anaesthetised with pentobarbitone[2] Dosage: 0.3-10 nmol/kg/min Administration: Intravenous injection; 0.3-10 nmol/kg/min once Result: Dose-dependently decreased in mean systemic artery pressure and showd a more potent effect than GSNO. Caused dose-dependent inhibition of the response to 0.3 μM/kg ADP. |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 301.7±44.0 °C at 760 mmHg |
Melting Point | 102-108ºC |
Molecular Formula | C8H20N4O2 |
Molecular Weight | 204.270 |
Flash Point | 136.3±28.4 °C |
Exact Mass | 204.158630 |
PSA | 68.17000 |
LogP | 0.44 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.503 |
Storage condition | 20°C |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |